title: Anticipation of end stage renal disease in patients with autosomal dominant polycystic kidney disease in successive generations.
abstract: Autosomal dominant polycystic kidney disease is a disorder, which is inherited in 50% of offspring, irrelevant the sex and it has a variable clinical expressivity. Initially it was noticed that the clinical expression was interfamilial, but some studies found out that it was different. The aim of this study was to evaluate the age of onset of end-stage renal disease (ESRD) in affected parents in comparison with their offspring in successive generations. We studied 60 families of patients with autosomal dominant polycystic kidney disease (ADPKD). The diagnosis was done by echo criteria and we included only the patients for whom we knew precisely the onset of ESRD (affected parent and offspring), the sex of the parent who suffered from the disease, and offspring. We found out that the ESRD in ADPKD appears at the same age in affected parents and offspring (49,3 +/- 7,9 Vs 51,8 +/- 9,2, p = NS) irrelevant of the sex of the offspring. Patients with paternal inheritance (n = 38) were diagnosed to have ESRD earlier than their affected parents (47,9 +/- 8,3 Vs 52,2 +/- 9,2 p < 0,05), but patients with maternal inheritance had no difference (n = 22) (51,9 +/- 6,8 Vs 51,2 +/- 9,4, p = NS). In all the patients (60 couples) the survival rate was the same between affected parents and offspring (p = NS, Kaplan-Meier test), but significant differences were noticed between offspring with paternal inheritance in comparison with their parents (p < 0,05). In conclusion, we have detected that the onset of ESRD between patients with ADPKD in successive generations: a) Occurs in offspring as in their ancestors, b) anticipation was observed in 55% of couples, c) the sex of offspring does not have any relation with the renal death and d) the ESRD in patients with paternal inheritance occurs earlier in offspring than in their ancestors but not with maternal.
authors.affiliation: Renal Unit, General Hospital of Komotini, Sismanoglou, Greece. mavromatidis@otenet.gr
authors.forename: N
authors.initials: N
authors.lastname: Sotirakopoulos
authors.forename: T
authors.initials: T
authors.lastname: Tsitsios
authors.forename: M
authors.initials: M
authors.lastname: Stambolidou
authors.forename: C
authors.initials: C
authors.lastname: Cristodoulidou
authors.forename: S
authors.initials: S
authors.lastname: Spaia
authors.forename: K
authors.initials: K
authors.lastname: Mavromatidis
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D020022:Genetic Predisposition to Disease / Q000453:epidemiology*; D006115:Greece / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000453:epidemiology* / Q000235:genetics* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010375:Pedigree; D016891:Polycystic Kidney, Autosomal Dominant / Q000453:epidemiology* / Q000235:genetics*; D011237:Predictive Value of Tests; D011336:Probability; D006435:Renal Dialysis; D012307:Risk Factors; D017678:Sex Distribution; D015996:Survival Rate